Journals / Tüberküloz ve Toraks / 2013 / Cilt: 61 - Sayı: 2

Küçük hücreli dışı akciğer kanseri olan hastalarda evrelere göre yaşam kalitesi ve egzersiz kapasitesinin karşılaştırılması

Comparison of health-related quality of life and exercise capacity according to stages in patients with non-small cell lung cancer

Pages
131–139
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, we can conclude that reduced exercise capacity negatively impacts functional categories of health related quality of life of patients with advanced-stage NSCLC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study is to compare the exercise capacity and health-related quality of life parameters according to stages of patients with non-small cell lung cancer (NSCLC).
📊
Key Findings & Data:Materials and Methods: Fifty-two patients (who are able to ambulate independently) with stage I-II (group early-stage, n= 17) and stage IIIA-IV NSCLC (group advanced-stage, n= 35) were included.
💡
Conclusion & Impact:Therefore, we can conclude that reduced exercise capacity negatively impacts functional categories of health related quality of life of patients with advanced-stage NSCLC.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study is to compare the exercise capacity and health-related quality of life parameters according to stages of patients with non-small cell lung cancer (NSCLC). Materials and Methods: Fifty-two patients (who are able to ambulate independently) with stage I-II (group early-stage, n= 17) and stage IIIA-IV NSCLC (group advanced-stage, n= 35) were included. Exercise capacity (six minute walking test), strength of the peripheral muscle (Back and Leg Dynamometer), performance status (Karnofsky performance status scale), health-related quality of life- HRQOL (European Organization for Research and Treatment of Cancer Quality of life measure and Short Form-36 Health Survey), depression and anxiety (Hospital Anxiety and Depression Scale) were evaluated. Results: No difference was found in age, body mass index, respiratory symptoms and the distribution of disease cell types between two groups (p> 0.05). In advanced-stage group, pulmonary function test values, peripheral muscle strength, walking distance and health-related quality of life scores especially the categories of functional capacity and pain were established significantly lower compared to early-stage group (p≤ 0.05). Depression and anxiety levels were confirmed to be similar between groups (p> 0.05). Conclusion: The exercise capacity of patients with advanced-stage NSCLC is lower due to reduced pulmonary functions and peripheral muscle strength compared to patients with early-stage NSCLC. Therefore, we can conclude that reduced exercise capacity negatively impacts functional categories of health related quality of life of patients with advanced-stage NSCLC.

Özet

Giriş: Çalışmamızın amacı; küçük hücreli dışı akciğer kanseri (KHDAK) hastalarında egzersiz kapasitesi ve sağlıkla ilgili yaşam kalitesi parametrelerini evrelere göre karşılaştırmaktır. Materyal ve Metod: Evre I-II (grup erken evre, n= 17) ve evre IIIA-IV olan (grup ileri evre, n= 35) 52 (bağımsız yürüyebilen) KHDAK hastası çalışmaya dahil edildi. Egzersiz kapasitesi (altı dakika yürüme testiyle), periferal kas kuvveti (sırt ve bacak dinamometresiyle), performans düzeyi (Karnofsky performans skalasıyla), sağlıkla ilgili yaşam kalitesi [European Organization for Research and Treatment of Cancer Yaşam Kalitesi Anketi (EORTC QLQ-C30) ve Short Form-36 (SF-36) anketiyle], depresyon ve kaygı düzeyi (Hastane Anksiyete ve Depresyon skalasıyla) değerlendirildi. Bulgular: İki grup arasında yaş, beden kitle indeksi, solunum semptomları ve hücre tipi dağılımı açısından fark bulunmadı (p> 0.05). İleri evre grupta solunum fonksiyon testi değerleri, periferal kas kuvveti, yürüme mesafesi, yaşam kalitesinin özellikle fonksiyonel kapasite ve ağrı kategorileri skorları erken evre gruba göre düşüktü (p≤ 0.05). Depresyon ve anksiyete sonuçları her iki grupta benzer bulundu (p> 0.05). Sonuç: İleri evre KHDAK hastalarında egzersiz kapasitesi; azalmış solunum fonksiyonları ve periferal kas kuvveti nedeniyle erken evre KHDAK hastalarına göre daha fazla azalmaktadır. Bu nedenlerle; KHDAK hastalarında azalmış egzersiz kapasitesinin hastaların yaşam kalitesinin özellikle fonksiyonel kategorilerini olumsuz olarak etkilediğini düşünmekteyiz.

🔖

Cite This Article

ERSÖZ, H., ÖNEN, A., AKKOÇLU, A., YILMAZ, E., ÖZALEVLİ, S., YEĞİN, A. (2022). Küçük hücreli dışı akciğer kanseri olan hastalarda evrelere göre yaşam kalitesi ve egzersiz kapasitesinin karşılaştırılması. Tüberküloz ve Toraks, Cilt: 61 - Sayı: 2, 131–139. https://ajindex.com/articles/618638

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ozturk A, Sarihan S, Ercan I, Karadag M. Evaluating quality of life and pulmonary function of long-term survivors of non- small cell lung cancer treated with radical or postoperative ra- diotherapy. Am J Clin Oncol 2009; 32: 65-72. 2.Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC. The evolving role of histology in the management of advanced non-small cell lung cancer. J Clin Oncol 2010; 28: 5311-20. 3.Yang P. Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol 2009; 471: 469-86. 4.Akin S, Can G, Aydiner A, Ozdilli K, Durna Z. Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs 2010; 14: 400-9. 5. Ozalevli S, Ilgin D, Karaali HK, Bulac S, Akkoclu A. The effect of in-patient chest physiotherapy in lung cancer patients. Support Care Cancer 2010; 18: 351-8. 6. Price D, McGrath PA, Rafii A, Buckinham B. The validation of visual analogue scale as ratio scale measure for chronic and experimental pain. Pain 1983; 17: 45-56. 7. American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36. 8. American Thoracic Society: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7. 9. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81. 10. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzic- ha JA. Usefulness of the Modified Medical Research Council (MMRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-6. 11. Karnofsky DA, Burchenal JH. The clinical evaluation of che- motherapeutic agents in cancer. In: MacLeod CM (ed). Evalu- ation of Chemotherapeutic Agents. New York: Columbia Uni- versity Press, 1949: 191-205. 12. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76. 13.Cankurtaran ES, Ozalp E, Soygur H, Ozer S, Akbiyik DI, Bot- tomley A. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. Eur J Cancer Care 2008; 17: 98-104. 14.Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Us- herwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 1